Drugs / Spedox-6
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07064018 | Apr 2025 → Dec 2029 expected | cervical cancer, non-small cell lung carcinoma, ovarian cancer, soft tissue sarcoma +1 | University of California, Irvine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Spedox-6 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07064018 ↗ |
| Route | Intravenous | “Given Intravenously (IV)” NCT07064018 ↗ |